Skip to Main Content


The Yale SPORE in Lung Cancer is the result of an $11 million grant from the National Cancer Institute in an effort to harness the strengths of academic cancer centers by bringing together experts in oncology, immunobiology, pharmacology, molecular biology, pathology, epidemiology, and addiction science to collaborate on projects focused on non-small cell lung cancer, one of the world’s most prevalent and lethal forms of cancer. The SPORE in Lung Cancer will focus on three primary projects during the next funding period. Each project will include a clinical trial to further evaluate the research, and translate it from the lab to the clinic